Background {#Sec1}
==========

The International Union of Immunological Societies (IUIS) Expert Committee on Primary Immunodeficiency met in London on the 14th and 15th March 2015 to update the classification of human primary immunodeficiencies (PIDs). This report represents the most current and complete catalogue of known PIDs. It serves as a reference for these conditions and provides a framework to help in the diagnostic approach to patients suspected to have PID.

As in previous reports, we have classified the conditions into major groups of PIDs and these are now represented in 9 different tables (Tables [1](#Tab1){ref-type="table"}, [2](#Tab2){ref-type="table"}, [3](#Tab3){ref-type="table"}, [4](#Tab4){ref-type="table"}, [5](#Tab5){ref-type="table"}, [6](#Tab6){ref-type="table"}, [7](#Tab7){ref-type="table"},[8](#Tab8){ref-type="table"} and [9](#Tab9){ref-type="table"}). In each table, we list the condition, its genetic defect if known and the major immunological and in some conditions the non-immunological abnormalities associated with the disease. This year we have added the gene OMIM number as well as the phenotype OMIM number for ease of reference.Table 1Immunodeficiencies affecting cellular and humoral immunityDiseaseGenetic defect/Presumed pathogenesis\
Gene OMIMInheritanceCirculating T cellsCirculating B cellsSerum IgAssociated FeaturesPhenotype\
OMIM numberT^−^B^+^ Severe Combined Immunodeficiency (SCID) γc deficiencyMutation of *IL2RG*\
Defect in γ chain of receptors for IL-2, -4, -7, -9, -15, -21\
308380XLMarkedly decreasedNormal or increasedDecreasedMarkedly decreased NK cells;300400 JAK3 deficiencyMutation of *JAK3*\
Defect in Janus activating kinase 3\
600173ARMarkedly decreasedNormal or increasedDecreasedMarkedly decreased NK cells;600802 IL7Rα deficiencyMutation of *IL7RA*\
Defect in IL-7 receptor α chain\
146661ARMarkedly decreasedNormal or increasedDecreasedNormal NK cells608971 CD45 deficiencyMutation of *PTPRC*\
Defect in CD45\
151460ARMarkedly decreasedNormalDecreasedNormal γ/δ T cells608971 CD3δ deficiencyMutation of *CD3D*\
Defect in CD3δ, chain of T cell antigen receptor complex\
186790,ARMarkedly decreasedNormalDecreasedNormal NK cells\
No γ/δ T cells615617 CD3ε deficiencyMutation of *CD3E*\
Defect in CD3ε chain of T cell antigen receptor complex\
186830,ARMarkedly decreasedNormalDecreasedNormal NK cells\
No γ/δ T cells615615 CD3ζ deficiencyMutation of *CD3Z*\
Defect in CD3ζ chain of T cell antigen receptor complex\
186780ARMarkedly decreasedNormalDecreasedNormal NK cells\
No γ/δ T cells610163 Coronin-1A deficiencyMutation of *CORO1A* Defective thymic egress of T cells and defective T cell locomotion\
605000ARMarkedly decreasedNormalDecreasedDetectable thymus\
EBV-associated B-cell lymphoproliferation615401T^−^B^−^ SCID DNA recombination defects (for additional DNA repair defects see Table [2](#Tab2){ref-type="table"}) RAG 1 deficiencyMutation of *RAG1*\
Defective VDJ recombination; defect of recombinase activating gene (RAG) 1\
179615ARMarkedly decreasedMarkedly decreasedDecreased601457 RAG 2 deficiencyMutation of *RAG2*\
Defective VDJ recombination; defect of recombinase activating gene (RAG) 2\
179616ARMarkedly decreasedMarkedly decreasedDecreased601457 DCLRE1C (Artemis) deficiencyMutation of *ARTEMIS*\
Defective VDJ recombination; defect in Artemis DNA recombinase-repair protein\
605988ARMarkedly decreasedMarkedly decreasedDecreasedRadiation sensitivity602450 DNA PKcs deficiencyMutation of *PRKDC* Defective VDJ recombination; defect in DNA PKcs\
Recombinase repair protein\
600899ARMarkedly decreasedMarkedly decreasedvariableRadiation sensitivity, microcephaly and developmental defects\
Autoimmunity and granuloma615966  Cernunnos/XLF deficiencyMutation of *Cernunnos* Defective VDJ recombination; defect in Cernunnos\
611290ARMarkedly decreasedMarkedly decreasedDecreasedRadiation sensitivity, microcephaly and developmental defects611291 DNA ligase IV deficiencyMutation of *LIG4* Defective VDJ recombination; defect in DNA ligase IV\
601837ARMarkedly decreasedMarkedly decreasedDecreasedRadiation sensitivity, microcephaly and developmental defects606593 Reticular dysgenesis, AK2 deficiencyMutation of *AK2*\
Defective maturation of lymphoid and myeloid cells (stem cell defect)\
Defect in mitochondrial adenylate kinase 2.\
103020ARMarkedly decreasedDecreased or normalDecreasedGranulocytopenia and deafness267500 Adenosine deaminase (ADA) deficiencyMutation of *ADA*\
Absent ADA activity, elevated lymphotoxic metabolites (dATP, S-adenosyl homocysteine)\
608958ARAbsent from birth (null mutations) or progressive decreaseAbsent from birth of progressive decreaseProgressive decreaseDecreased NK cells, often with costochondral junction flaring, neurological features, hearing impairment, lung and liver manifestations; partial ADA deficiency may lead to delayed or milder presentation102700 Combined immunodeficiencies generally less profound than severe combined immunodeficiency DOCK2 deficiencyMutations in *DOCK2* required for RAC1 activation, actin polymerization, T-cell proliferation, chemokine-induced lymphocyte migration and NK-cell degranulation\
603122ARDecreased. Poor response to PHA. Low TRECsNormalDecreased/ Normal. Poor antibody responsesNormal NK numbers, but defective function. Impaired interferon responses in hematopoietic and non-hematopoietic cells616433 CD40 ligand deficiencyMutation of *CD40LG* Defects in CD40 ligand (CD40L; also called TNFSF5 or CD154) cause defective isotype switching and impaired dendritic cell signaling\
300386XLNormal; may progressively decreasesIgM^+^ and sIgD^+^ B cells present, other surface isotype positive B cells absentIgM increased or normal, other isotypes decreasedNeutropenia, thrombocytopenia; hemolytic anemia, biliary tract and liver disease, opportunistic infections308230 CD40 deficiencyMutation of *CD40 (*also called TNFRSF5)\
Defects in CD40 cause defective isotype switching and impaired dendritic cell signaling\
109535ARNormalIgM^+^ and IgD^+^ B cells present, other isotypes absentIgM increased or normal, other isotypes decreasedNeutropenia, gastrointestinal and liver/biliary tract disease, opportunistic infections606843 ICOS deficiencyMutations in *ICOS;* a co-stimulatory molecule expressed on T cells\
604558ARNormalNormalLowRecurrent infections; autoimmunity, gastroenteritis, may have granulomas607594 CD3γ deficiencyMutation of *CD3G.* Defect in CD3γ component of the T cell antigen receptor complex\
186740ARNormal, but reduced TCR expressionNormalNormal615607 CD8 deficiencyMutation of *CD8A.* Defects of CD8 α chain, important for maturation and function of CD8 T cells\
186910ARAbsent CD8, normal CD4 cellsNormalNormal ZAP-70 deficiencyMutation in ZAP70 intracellular signaling kinase, acts downstream of TCR\
176947ARDecreased CD8, normal CD4 cellsNormalNormalAutoimmunity in some cases269840 MHC class I deficiencyMutations in *TAP1*, gene, causing MHC class I non-expression\
170260ARDecreased CD8, normal CD4 cells;\
absent MHC I expression on lymphocytesNormalNormalVasculitis; pyoderma gangrenosum604571 MHC class I deficiencyMutations in *TAP2*, gene, causing MHC class I non-expression\
170261ARDecreased CD8, normal CD4 cells;\
absent MHC I expression on lymphocytesNormalNormalVasculitis; pyoderma gangrenosum604571 MHC class I deficiencyMutations in *TAPBP* (tapasin) gene, causing MHC class I non-expression\
601962ARDecreased CD8, normal CD4 cells;\
absent MHC I expression on lymphocytesNormalNormalVasculitis; pyoderma gangrenosum604571 MHC class I deficiencyMutations in *B2M* gene, causing MHC class I non-expression\
109700ARDecreased CD8, normal CD4 cells;\
absent MHC I expression on lymphocytesNormalNormalSinopulmonary infections, cutaneous granuloma, hypoproteinemia. Absent expression of β2m associated proteins like MHC-I, CD1a, and CD1b, CD1c on β2m-deficient cellsnot yet assigned MHC class II deficiency group AMutation in transcription factors for MHC class II proteins (*CIITA* gene)\
600005ARDecreased CD4 cells\
Absent MHC II expression on lymphocytesNormalNormal or decreasedFailure to thrive, diarrhea, respiratory tract infections liver/biliary tract disease209920 MHC class II deficiency\
group BMutation in transcription factors for MHC class II proteins *RFXANK* gene\
603200ARDecreased CD4 cells\
Absent MHC II expression on lymphocytesNormalNormal or decreasedFailure to thrive, diarrhea, respiratory tract infections liver/biliary tract disease209920 MHC class II deficiency group CMutation in transcription factors for MHC class II proteins *RFX5*, gene)\
601863ARDecreased CD4 cells\
Absent MHC II expression on lymphocytesNormalNormal or decreasedFailure to thrive, diarrhea, respiratory tract infections liver/biliary tract disease209920 MHC class II deficiency\
group DMutation in transcription factors for MHC class II proteins (*RFXAP* gene\
601861ARDecreased CD4 cells\
Absent MHC II expression on lymphocytesNormalNormal or decreasedFailure to thrive, diarrhea, respiratory tract infections liver/biliary tract disease209920 ITK deficiencyMutations in *ITK* encoding IL-2 inducible T cell kinase required for TCR-mediated activation\
186973ARProgressive decreaseNormalNormal or decreasedEBV associated B cell lymphop-roliferation, lymphoma\
Normal or decreased IgG613011 MAGT1 deficiencyMutations in *MAGT1*, Impaired Mg^++^ flux leading to impaired TCR signaling 300715XLDecreased CD4 cells reduced numbers of RTE, impaired T-cell proliferation in response to CD3NormalNormalEBV infection, lymphoma; viral infections, respiratory and GI infections,300853 DOCK8 deficiencyMutations in *DOCK8* encoding a dedicator of cytokinesis regulator of intracellular actin reorganisation\
611432ARDecreased; Impaired T lymphocyte proliferation; Treg deficiency and poor functionDecreased; low CD27+ memory B cellsLow IgM, increased IgEDecreased NK cells with impaired function, hypereosinophilia, recurrent infections; severe atopy, extensive cutaneous viral and staphylococcal infections, susceptibility to cancer. Defects in peripheral B tolerance.243700 RhoH deficiencyMutations in *RHOH* -- an atypical Rho GTPase transducing signals downstream of various membrane receptors\
602037ARNormal\
low naïve T cells and RTE, restricted T cell repertoire and impaired T cells proliferation in response to CD3 stimulation.NormalNormalHPV infection, lymphoma, lung granulomas, molluscum contagiosum,not yet assigned MST1 deficiencyMutations in *STK4* -- a serine/threonine kinase\
604965ARDecreased increased proportion of terminal differentiated effector memory cells (TEMRA), low naïve T cells, restricted T cell repertoire in the TEMRA population and impaired T cells proliferationDecreasedHighRecurrent bacterial, viral, and candidal infections; intermittent neutropenia; EBV-driven lymphoproliferation; lymphoma; Congenital heart disease, autoimmune cytopenias; HPV infection.614868  TCRα deficiencyMutations in *TRAC* -- essential component of the T cell receptor\
186880ARNormal All CD3 T cells expressed TCRγδ (or may be better to say: TCRαβ T-cell deficiency), impaired T cells proliferationNormalNormalRecurrent viral, bacterial and fungal infections, immune dysregulation autoimmunity, and diarrhea.615387 LCK deficiencyDefects in *LCK* -- a proximal tyrosine kinase that interacts with TCR\
153390ARNormal total numbers but CD4+ T-cell lymphopenia, low Treg numbers, restricted T cell repertoire and impaired TCR signalingNormalNormal IgG and IgA and increased IgMDiarrhea, recurrent infections, immune dysregulation autoimmunity,615758 MALT1 deficiencyMutations in *MALT1* --\
a caspase-like cysteine protease that is essential for nuclear factor-kappa-B activation\
604860ARNormal number but impaired T cells proliferationNormalNormal\
Impaired antibody responseBacterial, fungal and viral infections615468 CARD11 deficiencyDefects in *CARD11* -- acts as a scaffold for NF-КB activity in the adaptive immune response\
607210ARNormal predominance of naive T-lymphocyte, impaired T cells proliferationNormal predominance of transitional B lymphocytes,Absent/lowPneumocystis jirovicii pneumonia, bacterial infections,615206 BCL10 deficiencyMutations in *BCL10* which encodes the B cell CLL / lymphoma 10 protein that forms a heterotrimer with Malt1 and CARD family adaptors and plays a role in NF-kB signaling\
603517ARNormal numbers, low memory T and Tregs, decreased proliferation to antigen and anti-CD3Normal number; decreased memory and switched B cellsLowRecurrent bacterial and viral infections, candidiasis, gastroenteritis616098 IL-21 deficiencyMutation in *IL21*\
605384ARNormal number.\
Normal/low functionLowIgG deficiencySevere early onset colitis615767 IL-21R deficiencyDefects in *IL21R* -- together with common gamma chain binds IL-21\
605383ARAbnormal T cell cytokine production; Abnormal T cell proliferation to specific stimuliNormalNormal but impaired specific responsesSuspectibility to cryptoporidia and pneumocystis and cholangitis615207 OX40 deficiencyDefects in *OX40 (TNFRSF4*) encoding a co-stimulatory molecule expressed on activated T cells\
600315ARNormal T cell numbers; decreased antigen specific memory CD4+ cellsNormal B cell numbers; reduced frequency of memory B cellsNormalKaposi's sarcoma; impaired immunity to HHV8615593 IKBKB deficiencyDefects in *IKBKB*, encoding IkB 2 kinase 2, a component of the NF-kB pathway\
603258ARNormal total T cells; absent regulatory and γδ T cells; impaired TCR activationNormal B cell numbers; impaired BCR activation;DecreasedRecurrent bacterial, viral and fungal infections; clinical phenotype of SCID615592 LRBA deficiencyMutations in *LRBA* (lipopolysaccharide responsive beige-like anchor protein)\
606453ARNormal or decreased CD4 numbers; T cell dysregulationLow or normal numbers of B cellsReduced I IgG and IgA in mostRecurrent infections, inflammatory bowel disease, autoimmunity; EBV infections614700 CD27 deficiencyMutations in *CD27* (*TNFRSF7*) encoding TNF-R member superfamily required for generation and long-term maintenance of T cell immunity\
186711ARNormalNo memory B cellsHypogamma-globulinaemia following EBV infectionClinical and immunologic features triggered by EBV infection, HLH\
Aplastic anaemia, Lymphoma,\
hypogammaglobulinemia,\
Low iNKT cells615122 NIK deficiencyMutation in *MAP3K14*, encoding NIK (NF-kB-inducing kinase)\
604655ARNormal number; impaired proliferation in response to antigen stimulation. Polycloncal Vβ repertoiresDecreased total peripheral B cell and switched memory B cellsHypogamma-globulinaemiaRecurrent bacterial, viral and Cryptosporidium infections. Low NK cell number and defective NK cell activationNot yet assigned CTPS1 deficiencyMutation in *CTPS1*, encoding CTP synthase 1, essential for lymphocyte proliferation\
123860ARNormal or decreased number\
Normal or decreased proliferationNormal/low numberNormal/high IgGRecurrent/chronic viral infections specially EBV and VZV, bacterial infections, EBV-driven\
B-cell non-Hodgkin lymphoma615897 Omenn syndromeHypomorphic mutations in *RAG1, RAG2*, *Artemis, IL7RA*, *RMRP, ADA, DNA Ligase IV, IL2RG*, *AK2*, or associated with DiGeorge syndrome; some cases have no defined gene mutationPresent; restricted T cell repertoire and impaired functionNormal or decreasedDecreased, except for increased IgEErythroderma, eosinophilia, adenopathies, hepatosplenomegaly603554Total no. of genes in Table [1](#Tab1){ref-type="table"}: 49New genes added: *DOCK2, B2M, IL21*, *MAP3K14, CTPS1*Notes: Infants with SCID who have maternal T cell engraftment may have allogeneic T cells present even in normal numbers, but that do not function normally; these cells may cause autoimmune cytopenias or graft versus host disease. Hypomorphic mutations in several of the genes that when affected by null mutations cause SCID may result in Omenn syndrome (OS), or "leaky" SCID or a less profound combined immunodeficiency or CID phenotype. Both OS and leaky SCID can be associated with \>300 autologous T cells/uL of peripheral blood and reduced rather than absent proliferative responses; Individuals with partially defective, or leaky, mutations are generally more mildly affected compared with those with typical SCID caused by null mutations. A spectrum of clinical findings including typical SCID, OS, leaky SCID, CID, granulomas with T lymphopenia, autoimmunity and CD4+ T lymphopenia can be found in an allelic series of *RAG1* and other SCID associated genes. RAC2 deficiency is a disorder of leukocyte motility and is reported in Table [5](#Tab5){ref-type="table"}; however, one patient with RAC2 deficiency had absent T cell receptor excision circles (TRECs) by newborn screening, though T cell numbers and mitogen responses were not impaired. For additional syndromic conditions with T cell lymphopenia, such as DNA repair defects, cartilage hair hypoplasia, IKAROS deficiency and NEMO syndrome, see Tables [2](#Tab2){ref-type="table"} and [6](#Tab6){ref-type="table"}; however, it should be noted that individuals with the most severe manifestations of these disorders could have clinical signs and symptoms of SCIDUNC119 deficiency has been removed from this version of the classification tables, as the *UNC119* variant reported previously has been identified as a polymorphism in unaffected individuals (Gorska MM, Alam R. A mutation in the human Uncoordinated 119 gene impairs TCR signaling and is associated with CD4 lymphopenia. *Blood*. 2012 Feb 9;119(6):1399--406. doi: 10.1182/blood-2011-04-350686. Epub 2011 Dec 19). See Erratum (Blood. 2014 Jan 16;123(3):457)*XL* X-linked inheritance, *AR* autosomal recessive inheritance, *AD* autosomal dominant inheritance, *SCID* severe combined immune deficiency, *EBV* epstein barr virus, *Ca* ^*++*^ calcium, *MHC* major histocompatibility complex, *RTE* recent thymic emigrants, *HPV* human papillomavirusTable 2Combined immunodeficiencies with associated or syndromic featuresDiseaseGenetic defect/Presumed pathogenesis\
OMIM number gene locusInheritanceCirculating T cellsCirculating B cellsSerum IgAssociated featuresOMIM number\
Phenotype1. Congenital thrombocytopenia Wiskott-Aldrich syndrome (WAS)Mutations in *WAS*; cytoskeletal and immunologic synapse defect affecting haematopoietic stem cell derivatives\
301000XLProgressive decrease, Abnormal lymphocyte responses to anti-CD3Normal numbersDecreased IgM: antibody to polysaccharides particularly decreased; often increased IgA and IgEThrombocytopenia with small platelets; eczema; lymphoma; autoimmune disease; IgA nephropathy; bacterial and viral infections. XL thrombocytopenia is a mild form of WAS, and XL neutropenia is caused by missense mutations in the GTPase binding domain of WASP300392 WIP deficiencyMutations in *WIPF1*; cytoskeletal and immunologic synapse defect affecting haematopoietic stem cell derivatives 602357ARReduced, Defective lymphocyte responses to anti-CD3LowNormal, except for increased IgERecurrent infections; eczema; thrombocytopenia. WAS-*like* phenotype.6144932. DNA repair defects (other than those in Table [1](#Tab1){ref-type="table"}) Ataxia-telangiectasiaMutations in *ATM*; disorder of cell cycle check-point and DNA double- strand break repair\
607585ARProgressive decrease, abnormal proliferation to mitogensNormalOften decreased IgA, IgE and IgG subclasses; increased IgM monomers; antibodies variably decreasedAtaxia; telangiectasia; pulmonary infections; lymphoreticular and other malignancies; increased alpha fetoprotein and increased radiosensitivity; chromosomal instability208900 Nijmegen breakage syndromeHypomorphic mutations in *NBS1*\
(*Nibrin*); disorder of cell cycle checkpoint and DNA double- strand break repair\
602667ARProgressive decreaseVariably reducedOften decreased IgA, IgE and IgG subclasses; increased IgM; antibodies variably decreasedMicrocephaly; bird-like face; lymphomas; solid tumors; increased radiosensitivity; chromosomal instability251260 Bloom syndromeMutations in *BLM (RECQL3*); encoding DNA helicase RecQ protein-like 3 helicase\
604610ARNormalNormalReducedShort stature; bird like face; sun-sensitive erythema; marrow failure; leukemia; lymphoma; chromosomal instability210900 Immunodeficiency with centromeric instability and facial anomalies (ICF1)Mutations in DNA methyltransferase*DNMT3B* (ICF1) resulting in defective DNA methylation 602900;ARDecreased or normal; responses to PHA may be decreasedDecreased or normalHypogammaglobulinemia; variable antibody deficiencyFacial dysmorphic features; macroglossia; bacterial/opportunistic infections; malabsorption; cytopenias; malignancies; multiradial configurations of chromosomes 1, 9, 16; no DNA breaks242860 Immunodeficiency with centromeric instability and facial anomalies (ICF2)Mutations in *ZBTB24* (ICF2)\
614064ARDecreased or normal;\
Responses to PHA may be decreasedDecreased or normalHypogammaglobulinemia; variable antibody deficiencyFacial dysmorphic features; macroglossia; bacterial/opportunistic infections; malabsorption; cytopenias; malignancies; multiradial configurations of chromosomes 1, 9, 16;614069 PMS2 deficiencyMutations in *PMS2*, resulting in Class Switch recombination deficiency due to impaired mismatch repair\
600259ARNormalReduced B cells, switched and non-switchedLow IgG and IgA, elevated IgM, abnormal antibody responsesRecurrent infections; café-au-lait spots; lymphoma, colorectal carcinoma, brain tumor276300 RNF168 deficiencyMutations in *RNF168*, resulting in defective DNA double-strand break repair (RIDDLE syndrome) 612688ARNormalNormalLow IgG, IgM, or low IgAShort stature; mild defect of motor control to ataxia; normal intelligence to learning difficulties; mild facial dysmorphism to microcephaly; increased radiosensitivity611943 MCM4 deficiencyMutations in *MCM4* (minichromosome maintenance complex component 4) gene involved in DNA replication and repair\
602638ARNormalNormalNormalViral infections (EBV, HSV, VZV)\
Adrenal failure\
Short stature\
Low NK cells6099813. Thymic defects with additional congenital anomalies DiGeorge syndrome\*Contiguous gene deletion in chromosome 22q11.2 or mutation of a gene within this deletion region, *TBX1*, encoding a transcription factor critical for development of thymus and adjacent embryonic structures\
602054*De novo* haplo-insufficiency (majority) or AD; phenocopies may have other as yet undefined genetic lesionsDecreased or normal; 5 % have \<1500 CD3 T cells/uL in neonatal periodNormalNormal or decreasedHypoparathyroidism, conotruncal cardiac malformation, velopalatal insufficiency, abnormal facies, intellectual disability and other abnormalities; often with 3 Mb interstitial deletion in 22q11.2 (or rarely with intragenic mutation of *TBX1*, deletion in 10p)188400 CHARGE syndrome due to CHD7 defectsVariable defects of the thymus and associated T cell abnormalities, often due to deletions or mutations in transcription regulator *CHD7*,\
608892*De novo* haplo-insufficiency (majority) or ADDecreased or normal; response to PHA may be decreasedNormalNormal or decreasedColoboma, heart anomaly, choanal atresia, mental retardation, genital and ear anomalies; some are SCID-like and have low TRECs214800 CHARGE syndrome due to SEMA3E defectsVariable defects of the thymus and associated T cell abnormalities, often due to deletions or mutations in transcription regulator, or semaphorin *SEMA3E* 608166*De novo* haplo-insufficiency (majority) or ADDecreased or normal; response to PHA may be decreasedNormalNormal or decreasedColoboma, heart anomaly, choanal atresia, mental retardation, genital and ear anomalies; some are SCID-like and have low TRECs214800 Winged helix deficiency (nude)\
 AAB: syndromic SCIDDefects in forkhead box N1 transcription factor encoded by *FOXN1*\
600838ARMarkedly decreasedNormalDecreasedAlopecia; nail dystropphy; severe infections abnormal thymic epithelium, impaired T cell maturation6017054. Immune-osseous dysplasias Cartilage hair hypoplasiaMutations in *RMRP* (RNase MRP RNA) Involved in processing of mitochondrial RNA and cell cycle control\
157660ARVaries from severely decreased (SCID) to normal; impaired lymphocyte proliferationNormalNormal or reduced antibodies variably decreasedShort-limbed dwarfism with metaphysealdysostosis, sparse hair, bone marrow failure, autoimmunity, susceptibility to lymphoma and other cancers, impaired spermatogenesis, neuronal dysplasia of the intestine250250 Schimke\
 Immunoosseous\
 DysplasiaMutations in *SMARCAL1;* involved in chromatin remodeling\
606622ARDecreasedNormalNormalShort stature, spondiloepiphyseal dysplasia, intrauterine growth retardation, nephropathy; bacterial, viral, fungal infections; may present as SCID; bone marrow failure2429005. Hyper-IgE syndromes (HIES) AD-HIES (Job or Buckley Syndrome)Dominant-negative heterozygous mutations in signal transducer and activator of transcription *STAT3*\
102582AD\
Often *de novo* mutationNormal overall Th-17 and T-follicular helper cells decreasedNormal; reduced switched and non-switched memory B cells; BAFF expression increasedElevated IgE; specific antibody production decreasedDistinctive facial features (broad nasal bridge), bacterial infections (boils and pulmonary abscesses, pneumatoceles) due to *S. aureus*, aspergillus, *Pneumocystis jirovecii*; eczema, mucocutaneous candidiasis, hyperextensible joints, osteoporosis and bone fractures, scoliosis, retention of primary teeth, aneurysm formation147060 Comel-Netherton syndromeMutations in *SPINK5* resulting in lack of the serine protease inhibitor LEKTI, expressed in epithelial cells\
605010ARNormalSwitched and non-switched B cells are reducedElevated IgE and IgA\
Antibody variably decreasedCongenital ichthyosis, bamboo hair, atopic diathesis, increased bacterial infections, failure to thrive256500 PGM3 deficiencyMutations inphosphoglycomutase 3 (*PGM3)* associated with a glycosylationand atopy\
172100ARCD8 and CD4 T cells may be decreasedReduced B and memory B cellsNormal or elevated Ig's, elevated IgE; eosinophiliaSevere atopy, autoimmunity, bacterial and viral infections, cognitive impairment, hypomyelination6158166. Dyskeratosis congenita (DKC) with bone marrow failure and dysfunctional telomere maintenance XL-DKC due to Dyskerin deficiencyMutations in *DKC1* encoding dyskerin\
300126XLProgressive decreaseProgressive decreaseVariable hypogammag-lobulinemiaIntrauterine growth retardation, microcephaly, nail dystrophy, recurrent infections, digestive tract involvement, pancytopenia, reduced number and function of NK cells. A severe phenotype with developmental delay and cerebellar hypoplasia is known as Hoyeraal-Hreidarsson Syndrome (HHS)305000 AR-DKC due to nucleolar protein family A member 2 (NHP2) deficiencyMutations in *NOLA2* (*NHP2*),\
component of the H/ACA ribonucleo-protein complex\
606470ARDecreasedVariableVariablePancytopenia, sparse scalp hair and eyelashes, prominent periorbital telangiectasia, hypoplastic/dysplastic nails613987 AR-DKC due to nucleolar protein family A member 3 (NHP3) or NOP10 deficiencyMutation in *NOLA3* (*NOP10, PCFT*), a component of the H/ACA ribonucleo-protein complex\
606471ARDecreasedVariableVariablePancytopenia, sparse scalp hair and eyelashes, prominent periorbital telangiectasia, hypoplastic/dysplastic nails224230 AR-DKC due to regulator of telomere elongation (RTEL1) deficiencyMutation in *RTEL1* encoding regulator of telomere elongation helicase 1 (RTEL1)\
608833AD or ARDecreasedVariableVariablePancytopenia, sparse scalp hair and eyelashes, prominent periorbital telangiectasia, hypoplastic/dysplastic nails. May present as HHS615190 AD-DKC due to TERC deficiencyMutation in *TERC* encoding telomerase RNA component\
602322ADVariableVariableVariableReticular hyperpigmentation of the skin, dystrophic nails, osteoporosis premalignant leukokeratosis of the oral mucosa, palmar hyperkeratosis, anemia, pancytopenia. May present as HHS127550 AD-DKC due to TERT deficiencyMutation in *TERT* encoding telomerase reverse transcriptase 187270AD or ARVariableVariableVariableReticular hyperpigmentation of the skin, dystrophic nails, osteoporosis premalignant leukokeratosis of the oral mucosa, palmar hyperkeratosis, anemia, pancytopenia. AD version is milder than the AR version which can resemble HHS613989 AD-DKC due to TINF2 deficiencyMutation in *TINF2* encoding telomerase interacting factor 2 604319ADVariableVariableVariableReticular hyperpigmentation of the skin, dystrophic nails, osteoporosis premalignant leukokeratosis of the oral mucosa, palmar hyperkeratosis, anemia, pancytopenia. May present as HHS613990 AD/AR -DKC due to TPP1 deficiencyMutation in adrenocortical dysplasia homolog (ACD) encoding TPP1 affecting the TELpatch domain resulting in failure to recruit telomerase to telomers\
609377AD/ARVariableVariableVariableReticular hyperpigmentation of the skin, dystrophic nails, osteoporosis leukoplakia of the oralmucosa, carcinoma, leukemia palmar hyperkeratosis, anemia, pancytopenia. May present as HHS AR-DKC due to DCLRE1B deficiencyMutation in DCLRE1B/ SNM1/APOLLO: DNA CROSS-LINK REPAIR PROTEIN 1B\
609683ARdyskeratosis congenita and Hoyeraal-Hreidarsson (HH) syndrome616353 AR-DKC due to PARN deficiencyMutation in PARN, POLYADENYLATE-SPECIFIC RIBONUCLEASE\
604212AR6163537. Defects of Vitamin B12 and Folate metabolism Transcobalamin 2 (TCN2) deficiencyMutation in *TCN2*; encoding a transporter of cobalamin into blood cells\
613441ARNormalVariableDecreasedMegaloblastic anaemia, pancytopaenia, if untreated for prolonged periods results in mental retardation275350 SLC46A1/PCFT deficiency causing hereditary folate malabsorbtionMutation in *SLC46A1*, encoding a proton coupled folate transporterARVariable numbers and activation profileVariableDecreasedMegaloblastic anaemia, failure to thrive, if untreated for prolonged periods results in mental retardation229050\
611672 Methylene-tetrahydrofolate dehydrogenase 1 (MTHFD1) deficiencyMutations in enzyme encoded by *MTHFD*, essential [for]{.ul} processing single-carbon folate derivativesARLowLowDecreasedMegaloblastic anaemia, failure to thrive, neutropenia, seizures, mental retardation601634\
1724608. Anhidrotic ectodermaldysplasia with immunodeficiency (EDA-ID) (EDA-ID. NEMO /IKBKG deficiencyMutations of *NEMO* (*IKBKG*), a modulator of NF-κB activation\
Defects in *IKBKG*, encoding NEMO, a component of the NF-κB pathway\
Mutations of NEMO (*IKBKG*), a modulator of NF-κB activation\
300248XLNormal or decreased; poor CR activation functionNormal\
Low B memory B cellsDecreased; poor specific antibody responses, absent antibody to polysaccharide antigensanhidrotic ectodermal dysplasia + specific antibody deficiency (lack of Ab response to polysac-charides) + various infections (mycobacteria and pyogens)\
Various infections (bacteria, mycobacteria, viruses and fungi); colitis, EDA (not in all patients); conical teeth, variable defects of skin pigmentation, monocyte dysfunction300291, 300584, 300301\
300640 EDA-ID IKBA gain of function mutationGain of function mutation in *IKBA (NFKIAB)*, encoding IκBα, a component of the NF-κB pathway\
Gain-of-function mutation of *IKBA*, resulting in impaired activation of NF-κB\
164008ADNormal total T cells;; impaired TCR activationNormal B cell numbers; impaired BCR activation;Decreased; poor specific antibody responses, absent antibody to polysaccharide antigensVarious infections (bacteria, mycobacteria, viruses and fungi); colitis, EDA (not in all patients); variable defects of skin, hair and teeth, T cell and monocyte dysfunction\
Anhidrotic ectodermal dysplasia + T cell defect + various infections: Recurrent bacterial, viral and fungal infections;6121329. Calcium channel defects ORAI-I deficiencyMutation in *ORAI1*, a Ca^++^ release-activated channel (CRAC) modulatory component\
610277ARNormal; defective TCR mediated activationNormalNormalAutoimmunity, anhydrotic ectodermic dysplasia, non-progressive myopathy612782 STIM1 deficiencyMutations in *STIM1*, a stromal interaction molecule 1\
605921ARNormal; defective TCR mediated activationNormalNormalAutoimmunity, anhydrotic ectodermal dysplasia, non-progressive myopathy61278310. Other defects Hepatic veno-occlusive disease with immunodeficiency (VODI)Mutations in nuclear body protein encoded by *SP110*\
604457ARNormal (decreased memory T cells)Normal (decreased memory B cells)Decreased IgG, IgA, IgM; absent germinal centers and tissue plasma cellsHepatic veno-occlusive disease; Susceptibility to *Pneumocystis jiroveci* pneumonia, CMV, candida; thrombocytopenia; hepatosplenomegaly; cerebrospinal leukodystropy235550 Facial dysmorphism, immunodeficiency, livedo, short stature (FILS) syndromeMutation in *POLE1*; Defective DNA replication\
174762ARLow naïve T cells; decreased T cell proliferationLow memory B cellsDecreased IgM and IgG; Lack of antibodies to polysaccharide antigensMild facial dysmorphism (malar hypoplasia, high forehead), livedo, short stature; recurrent upper and lower respiratory tract infections, recurrent pulmonary infections and recurrent meningitis615139 Immunodeficiency with multiple intestinal atresiasMutation in *TTC7A* (tetratricopeptide repeat (TPR) domain 7A) protein, of unkown function\
609332ARVariable, but sometimes absentNormalDecreasedMultiple intestinal atresias, often with intrauterine polyhydramnios and early demise; some with SCID phenotype243150 Vici syndrome due to EPG5 deficiencyMutations in *EPG5* encoding ectopic P-granules autophagy protein 5, involved in the formation of autolysosomes required for autophagyARProfound depletion of CD4+ cellsDefectiveDecreased (particularly IgG2)Agenesis of the corpus callosum, cataracts, cardiomyopathy, skin hypopigmentation, cleft lip/palate, recurrent infections, chronic mucocutaneous candidiasis242840\
615068 Purine nucleoside phosphorylase (PNP) deficiencyMutation of *PNP* leading to absent PNP, T cell and neurologic defects from elevated toxic metabolites, especially dGTP\
164050ARProgressive decreaseNormalNormal or decreasedAutoimmune haemolytic anemia, neurological impairment613179 HOIL1 deficiencyMutation of *HOIL1/RBCK1*, encoding a component of the linear ubiquitination chain assembly complex LUBAC, resulting in impaired activation of NF-κB\
610924ARNormal numbers,Normal, but decreased memory B cellsPoor antibody production to polysaccharide antigensBacterial infections (pyogens), autoinflammation. amylopectinosis615895 HOIP deficiencyMutation of *HOIP1 (/RNF31)*, encoding a component of the linear ubiquitination chain assembly complex LUBAC, resulting in impaired activation of NF-κB\
612487ARNormal numbersNormal, but decreased memory B cellsdecreasedBacterial infections (pyogens), autoinflammation. Amylopectinosis, LymphangiectasiaNot yet assigned Hennekam-lymphangiectasia-lymphedema syndromeMutation of *CCBE1*: (COLLAGEN AND CALCIUM-BINDING EGF DOMAIN-CONTAINING PROTEIN1)\
612753ARLow/variableLow/variabledecreasedLymphangiactasia and lymphedema with facial abnormalities and other dysmorphic features235510 STAT5b deficiencyMutations in *STAT5B* signal transducer and transcription factor, essential for normal signaling from IL-2 and 15, key growth factors for T and NK cells, as well as other cytokines\
604260ARModestly decreasedNormalNormalGrowth-hormone insensitive dwarfism, dysmorphic features, eczema, lymphocytic interstitial pneumonitis, autoimmunity245590Total no. of genes in Table [2](#Tab2){ref-type="table"}: 45New genes added: *TPP1, DCLRE1B, PARN, CCBE1, HOIP1, EPG5*Notes: T and B cell number and function in these disorders exhibit a wide range of abnormality; the most severely affected cases meet diagnostic criteria for SCID or leaky SCID and require immune system restoring therapy such as allogeneic hematopoietic cell transplantation\* Although TBX1 deletions are emphasized, data are lacking that demonstrate that isolated TBX1 haploinsufficiency (affecting solely the gene and none of the surrounding 22q11.2 region) explicitly causes T cell or immunologic deficiency in humansTable 3Predominantly antibody deficienciesDiseaseGenetic defect/Presumed pathogenesis\
Gene OMIMInheritanceSerum IgAssociated featuresPhenotype\
OMIM number1. Severe reduction in all serum immunoglobulin isotypes with profoundly decreased or absent B cells BTK deficiencyMutations in *BTK*, a cytoplasmic tyrosine kinase activated by crosslinking of the BCR\
300300XLAll isotypes decreased in majority of patients; some patients have detectable immunoglobulinsSevere bacterial infections; normal numbers of pro-B cells300755 μ heavy chain deficiencyMutations in μ heavy chain (*IGHM*); essential component of the pre-BCR\
147020ARAll isotypes decreasedSevere bacterial infections; normal numbers of pro-B cells601495 λ5 deficiencyMutations in λ5 (*IGLL1*); part of the surrogate light chain in the pre-BCR\
146770ARAll isotypes decreasedSevere bacterial infections; normal numbers of pro-B cells613500 Igα deficiencyMutations in Igα (*CD79A*); part of the pre-BCR and BCR 112205ARAll isotypes decreasedSevere bacterial infections; normal numbers of pro-B cells112205\
613501 Igβ deficiencyMutations in Igb (*CD79B*); part of the pre-BCR and BCR\
147245ARAll isotypes decreasedSevere bacterial infections; normal numbers of pro-B cells612692 BLNK deficiencyMutations in *BLNK*; a scaffold protein that binds to BTK 604615ARAll isotypes decreasedSevere bacterial infections; normal numbers of pro-B cells613502 PI3KR1 deficiencyMutations in *PIK3R1;* a kinase involved in signal transduction in multiple cell types. Complete loss of PI3K p85-alpha resulting in complete loss of B cell development\
171833ARAll isotypes decreasedSevere bacterial infections; decreased or absent pro-B cells615214 E47 transcription factor deficiencyMutations in *TCF3*; a transcription factor required for control of B cell development\
147141ADAll isotypes decreasedRecurrent bacterial infectionsNot yet assigned Thymoma with immunodeficiencyUnknownNoneOne or more isotypes may be decreasedBacterial and opportunistic infections; autoimmunity; decreased number of pro-B cells DiseaseGenetic defect/Presumed pathogenesisInheritanceSerum IgAssociated featuresOMIM number2. Severe reduction in at least 2 serum immunoglobulin isotypes with normal or low number of B cells Common variable immuno-deficiency disordersUnknownVariableLow IgG and IgA and/or IgMClinical phenotypes vary: most have recurrent infections, some have polyclonal lymphoproliferation, autoimmune cytopenias and/or granulomatous disease CD19 deficiencyMutations in *CD19*; transmembrane protein that amplifies signal through BCR 107265ARLow IgG and IgA and/or IgMRecurrent infections; May have glomerulonephritis613493 CD81 deficiencyMutations in *CD81*; transmembrane protein that amplifies signal through BCR 186845ARLow IgG, low or normal IgA and IgMRecurrent infections; May have glomerulonephritis613496 CD20 deficiencyMutations in *CD20;* a B cell surface receptor involved in B cell development and plasma cell differentiation\
112210ARLow IgG, normal or elevated IgM and IgARecurrent infections613495 CD21 deficiencyMutations in *CD21;* also known as complement receptor 2 and forms part of the CD19 complex\
120650ARLow IgG; impaired anti-pneumococcal responseRecurrent infections614699 TACI deficiencyMutations in *TNFRSF13B* (TACI); a TNF receptor family member found on B cells and is a receptor for BAFF and APRIL\
604907AD or AR or complexLow IgG and IgA and/or IgMVariable clinical expression240500 BAFF receptor deficiencyMutations in *TNFRSF13C* (BAFF-R); a TNF receptor family member found on B cells and is a receptor for BAFF\
606269ARLow IgG and IgM;Variable clinical expression613494 TWEAK deficiencyMutations in a cytokine *TWEAK (TNFSF12);* TNF-related weak inducer of apoptosis\
602695ADLow IgM and A; lack of anti-pneumococcal antibodyPneumonia, bacterial infections, warts; thrombocytopenia. neutropenianot yet assigned NFKB2 deficiencyMutations in *NFKB2*; an essential component of the noncanonical NF-κB pathwayADLow IgG and IgA and IgM; very low B cells in someRecurrent infections; adrenal insufficiency; ACTH deficiency; alopecia615577 MOGS deficiencyMutation in mannosyl-oligosaccharide glucosidase\
601336ARSevere hypogammaglobulinemia;Bacterial and viral infections; severe neurologic disease; also contains glycosylation type IIb (CDG-IIb),606056  *TRNT1 deficiency*Mutation in *TRNT1 a* template-independent RNA polymerase required for the maturation of cytosolic and mitochondrial transfer RNAs (tRNAs) 612907ARB cell deficiency and hypogammaglobulinemiacongenital sideroblastic anemia; deafness; developmental delay616084 TTC37 deficiency*Mutation in TTC37* gene\
614589ARPoor antibody response to pneumococcal vaccineRecurrent bacterial and viral infections; Abnormal hair findings: trichorrhexis nodosa2224703. Severe reduction in serum IgG and IgA with normal/elevated IgM and normal numbers of B cells AID deficiencyMutations in *AICDA* gene\
605257ARIgG and IgA decreased; IgM increasedBacterial infections; enlarged lymph nodes and germinal centers605258 UNG deficiencyMutations in *UNG*\
191525ARIgG and IgA decreased; IgM increasedEnlarged lymph nodes and germinal centers608106 INO80INO80 chromatin remodeling complex; mild DNA repair defect 610169ARIgG and IgA decreased; IgM increasedSevere bacterial infectionsnot yet assigned MSH6MSH6 gene defect part of mismatch repair \[MMR\] machinery); DNA repair defect\
600678ARVariable IgG, defects; increased IgM in some; normal B cells, low switched memory B cells; Ig-CSR and SHM defectsFamily or personal history of cancernot yet assigned4. Isotype or light chain deficiencies with generally normal numbers of B cells Activated PI3K-δMutation in *PIK3CD;* *p110 encoding for p110 subunit of PI3K*\
602839AD gain of functionReduced IgG2 and impaired antibody to pneumococci and hemophilusRespiratory infections, bronchiectasis; autoimmunity; chronic EBV, CMV infection615513 PI3KR1 loss of functionMutation in *PIK3R1* leading to mutations in p85α\
171833AD loss of function of p85α (leading to activation of PI3K-δ -- as above)Absent IgA, low IgGEBV, CMV viremia; growth retardation616005 Ig heavy chain mutations and deletionsMutation or chromosomal deletion at 14q32AROne or more IgG and/or IgA subclasses as well as IgE may be absentMay be asymptomatic IGKC deficiencyMutations in Kappa constant geneARAll immunoglobulins have lambda light chainAsymptomatic147200 Isolated IgG subclass deficiencyUnknownVariableReduction in one or more IgG subclassUsually asymptomatic; a minority may have poor antibody response to specific antigens and recurrent viral/bacterial infections IgA with IgG subclass deficiencyUnknownVariableReduced IgA with decrease in one or more IgG subclassRecurrent bacterial infections Specific antibody deficiency with normal Ig concentrations and normal numbers of B cellsUnknownVariableNormalReduced ability to produce antibodies to specific antigens Transient hypogammaglobulinemia of infancy with normal numbers of B cellsUnknownVariableIgG and IgA decreasedNormal ability to produce antibodies to vaccine antigens, usually not associated with significant infections CARD 11 gain of functionCARD11; scaffold for NF-kB activity in the adaptive immune response; gain of functionADCongenital B cell lymphocytosis. High B cell numbers due to constitutive NF-κB activationSplenomegaly; lymphadenopathy607210; 606445Total no. of gene in Table [3](#Tab3){ref-type="table"}: 28New genes added: *MOGS, TRNT1, TTC37, IN08, MSH6, PI3KR1 AD*Notes: Several autosomal recessive disorders that might previously have been called CVID have been added to Table [3](#Tab3){ref-type="table"}. CD81 is normally co-expressed with CD19 on the surface of B cells. As for CD19 mutations, mutations in CD81 result in normal numbers of peripheral blood B cells, low serum IgG and an increased incidence of glomerulonephritisCommon Variable Immunodeficiency Disorders (CVID) include several clinical and laboratory phenotypes that may be caused by distinct genetic and/or environmental factors. Some patients with CVID and no known genetic defect have markedly reduced numbers of B cells as well as hypogammaglobulinemia. Alterations in *TNFRSF13B (TACI)* and *TNFRSF13C (BAFF-R)* sequences may represent disease modifying mutations rather than disease causing mutations. A small minority of patients with XLP (Table [4](#Tab4){ref-type="table"}), WHIM syndrome (Table [6](#Tab6){ref-type="table"}), ICF (Table [2](#Tab2){ref-type="table"}), VOD1 (Table [2](#Tab2){ref-type="table"}), thymoma with immunodeficiency (Good syndrome) or myelodysplasia are first seen by an immunologist because of recurrent infections, hypogammaglobulinemia and normal or reduced numbers of B cells*XL* X-linked inheritance, *AR* autosomal recessive inheritance, *AD* autosomal dominant inheritance*; BTK* Bruton tyrosine kinase, *BLNK* B cell linker protein*AID* activation-induced cytidine deaminase, *UNG* uracil-DNA glycosylase, *Ig(κ)* immunoglobulin or κ light-chain typeTable 4Diseases of immune dysregulationDiseaseGenetic defect/Presumed pathogenesis\
Gene OMIMInheritanceCirculating T CellsCirculating B cellsFunctional defectAssociated FeaturesPhenotype OMIM\
number1. Familial hemophagocytic lymphohistiocytosis (FHL) syndromes 1.1. FHL syndromes without hypopigmentation  Perforin deficiency (FHL2)Mutations in *PRF1*; perforin is a major cytolytic protein\
170280ARIncreased activated T cellsNormalDecreased to absent NK and CTL activities cytotoxicityFever, Hepato-Splenomegaly (HSMG), Hemophagocytic lymphohistiocytosis (HLH), Cytopenias603553  (UNC13D / Munc13-4 deficiency (FHL3)Mutations in *UNC13D*; required to prime vesicles for fusion\
608897ARIncreased activated T cellsNormalDecreased to absent NK and CTL activities\
(cytotoxicity and/or\
degranulation)Fever, HSMG, HLH, Cytopenias,608898  Syntaxin 11 deficiency, (FHL4)Mutations in *STX11*, required for secretory vesicle fusion with the cell membrane\
605014ARIncreased activated T cellsNormalDecreased NK activity (cytotoxicity and/or degranulation)Fever, HSMG, HLH, Cytopenias,603552  STXBP2 / Munc18-2 deficiency (FHL5)Mutations in *STXBP2*, required for secretory vesicle fusion with the cell membrane\
601717AR or ADIncreased activated T cellsNormalDecreased NK and CTL activities (cytotoxicity and/or degranulation)Fever, HSMG, HLH, Cytopenias,613101  SH2D1A deficiency (XLP1)Mutations in *SH2D1A* encoding an adaptor protein regulating intracellular signaling\
300490XLNormal or increased activated T cellsReduced Memory B cellspartially defective NK cell and CTL cytotoxic activityClinical and immunologic features triggered by EBV infection: HLH, lymphoproliferation, Aplastic anaemia, lymphoma.\
Hypogammaglobulinemia, absent iNKT cells308240  XIAP deficiency (XLP2)Mutations in *XIAP/ BIRC4* encoding an inhibitor of apoptosis\
300079XLNormal or Increased activated T cells; low/normal iNK T cellsNormal or reduced Memory B cellsIncreased T cells susceptibility to apoptosis to CD95 and enhanced activation-induced cell death (AICD)EBV infection, Splenomegaly, lymphoproliferation HLH, Colitis, IBD, hepatitis\
Low iNKT cells300635 1.2. FHL syndromes with hypopigmentation  Chediak-Higashi syndromeMutations in *LYST*, impaired lysosomal trafficking\
606897ARIncreased activated T cellsNormalDecreased NK and CTL activities (cytotoxicity and/or degranulation)Partial albinism, recurrent infections, fever, HSMG, HLH\
Giant lysosomes, neutropenia, cytopenias, bleeding tendency, progressive neurological dysfunction214500  Griscelli syndrome, type2Mutations in *RAB27A* encoding a GTPase that promotes docking of secretory vesicles to the cell membrane\
603868ARNormalNormalDecreased NK and CTL activities (cytotoxicity and/or degranulation)Partial albinism, fever, HSMG, HLH, cytopenias607624  Hermansky-Pudlak syndrome, type 2Mutations in *AP3B1* gene, encoding for the β subunit of the AP-3 complex\
603401ARNormalNormalDecreased NK and CTL activities (cytotoxicity and/or degranulation)Partial albinism, recurrent infections, pulmonary fibrosis\
Increased bleeding, neutropenia, HLH608233  Hermansky-Pudlak syndrome, type 9Mutations in *PLDN*, encoding Pallidin, a component of the biogenesis of lysosome-related organelles complex-1 (BLOC-1)\
604310AR(Not assessed; leukopenia)(Not assessed, leukopenia)Decreased NK cell cytolytic activityOculocutaneous albinism, recurrent cutaneous infections, leukopenia, thrombocytopenia6141712. T regulatory cells genetic defects IPEX, immune dysregulation, polyendocrinopathy, enteropathy X-linkedMutations in *FOXP3*, encoding a T cell transcription factor\
300292XLNormalNormalLack of (and/or impaired function of) CD4^+^ CD25^+^ FOXP3^+^ regulatory T cells (Tregs)Autoimmune enteropathy, early onset diabetes, thyroiditis hemolytic anemia, thrombocytopenia, eczema\
Elevated IgE, IgA304790 CD25 deficiencyMutations in *IL2RA*, encoding IL-2Rα chain, 147730ARNormal to decreasedNormalNo CD4 + C25+ cells with impaired function of Tregs cellsLymphoproliferation, autoimmunity. Impaired T cell proliferation606367 CTLA4 deficiency (ALPSV)Mutations in *CTLA4*, encoding Cytotoxic T Lymphocyte antigen 4, a protein that negatively regulate T cell receptor signaling and T cell activation.\
123890ADDecreasedDecreasedImpaired function of Treg cells.Autoimmune cytopenias, enteropathy, interstitial lung disease, extra-lymphoid lymphocytic infiltration recurrent infections,616100 STAT3 GOF mutationsMutations in *STAT3*, encoding Signal Transducer and activator 3\
102582ADDecreasedDecreasedEnhanced STAT3 signaling, leading to increased Th17 cell differentiation, lymphoproliferation and autoimmunity. Decreased Treg cell numbers and impaired phenotypeLymphoproliferation, Solid organ autoimmunity, recurrent infections.6159523. Autoimmunity with or without lymphoproliferation APECED (APS-1), autoimmune polyendocrinopathy with candidiasis and ectodermal dystrophyMutations in *AIRE*, encoding a transcription regulator needed to establish thymic self-tolerance\
607358ARNormalNormalAIRE-1 serves as check-point in the thymus for negative selection of autoreactive T cells and for generation of TregsAutoimmunity: hypoparathyroidism hypothyroidism, adrenal insufficiency, diabetes, gonadal dysfunction and other endocrine abnormalities, chronic mucocutaneous candidiasis, dental enamel hypoplasia, alopecia areata\
Enteropathy, Pernicious anemia,240300 ITCH deficiencyMutations in *ITCH*, an E3 ubiquitin ligase catalyzes the transfer of ubiquitin to a signaling proteins in the cell including phospholipase Cγ1 (PLCγ1)\
606409ARNot assessedNot assessedItch deficiency may cause immune dysregulation by affecting both anergy induction in auto-reactive effector T cells and generation of TregsEarly-onset chronic lung disease (interstitial pneumonitis)\
Autoimmune disorder (thyroiditis, type I diabetes, chronic diarrhea/enteropathy, and hepatitis)\
Failure to thrive, developmental delay, dysmorphic facial features613385 Tripeptidyl-Peptidase II DeficiencyMutations in *TPP2*, encoding tripeptidyl-peptidase II, serine exopeptidase involved in extralysosomal peptide degradation\
190470ARDecreasedDecreasedTPP2 deficiency results in premature immunosenescence and immune dysregulationVariable lymphoproliferation, severe autoimmune cytopenias, hypergammaglobulinemia, recurrent infections,Not yet assigned3. Autoimmune lymphoproliferative syndrome (ALPS) ALPS-FASGerminal mutations in *TNFRSF6*, encoding CD95/Fas cell surface apoptosis receptor\*\*\
134637AD\
AR\*\*\*Increased CD4^−^CD8^−^TCRαβ double negative (DN) T cellsNormal, low memory B cellsApoptosis defect FAS mediatedSplenomegaly, adenopathies, Autoimmune cytopenias, increased lymphoma risk.\
IgG and A normal or increased\
Elevated FasL and IL-10, vitamin B12601859 ALPS-FASLGMutations in *TNFSF6*, Fas ligand for CD95 apoptosis\
134638ARIncreased DN T cellsNormalApoptosis defect FAS mediatedSplenomegaly, adenopathies, autoimmune cytopenias, SLE;\
Soluble FasL is not elevated601859 ALPS-Caspase10Mutations in *CASP10*, intracellular apoptosis pathway\
601762ADIncreased DN T cellsNormalDefective lymphocyte apoptosisAdenopathies, splenomegaly, autoimmunity.603909 ALPS-Caspase 8Mutations in *CASP8*, intracellular apoptosis and activation pathways\
601763ARSlightly increased DN T cellsNormalDefective lymphocyte apoptosis and activationAdenopathies, splenomegaly, Bacterial and viral infections,\
Hypogammaglobulinemia607271 FADD deficiencyMutations in *FADD* encoding an adaptor molecule interacting with FAS, and promoting apoptosis\
602457ARIncreased DN T cellsNormalDefective lymphocyte apoptosisFunctional hyposplenism,\
Bacterial and viral infections,\
Recurrent episodes of encephalopathy and liver dysfunction.613759 PRKC delta deficiencyMutations in *PRKCD*,\
encoding a member of the protein kinase C family critical for regulation of cell survival, proliferation and apoptosis\
176977ARNormalLow memory B cells and\
Elevation of CD5 B cellsApoptotic defect in B cellsRecurrent infections; EBV chronic infection\
Lymphoproliferation\
SLE-like autoimmunity (Nephrotic and antiphospholipid syndromes)\
HypoIgG6155594. Immune dysregulation with colitis IL-10 deficiencyMutations in *IL10*,\
encoding IL-10\
124092ARNormalNormalNo functional IL-10 secretionInflammatory bowel disease (IBD) Folliculitis,\
Recurrent respiratory diseases,\
Arthritis,not assigned IL-10Rα deficiencyMutations in *IL10RA*,\
encoding IL-10R1\
146933ARNormalNormalLeukocytes no response\
to IL-10IBD, Folliculitis,\
Recurrent respiratory diseases,\
Arthritis, Lymphoma613148 IL-10Rβ deficiencyMutations in *IL10RB*,\
encoding IL-10R2\
123889ARNormalNormalLeukocytes no response\
to IL-10, IL-22, IL-26, IL-28A, IL-28B, and IL-29IBD, Folliculitis,\
Recurrent respiratory diseases,\
Arthritis, Lymphoma612567 NFAT5 haploinsufficiencyHemizygous deletion of *NFAT5*\
604708ADNormalNormalDecreased memory B cells and plasmablastsIBD, recurrent sinopulmonary infectionsNot yet assigned5. Type 1 Interferonopathies TREX1 deficiency, Aicardi-Goutieres syndrome 1 (AGS1)Mutations in *TREX1*, encoding nuclease involves in clearing cellular nucleic debris\
606609AR\
AD\*\*\*\*\*Not assessedNot assessedIntracellular accumulation of abnormal single-stranded (ss) DNA species leading to increased CSF alpha-IFN productionProgressive encephalopathy Intracranial calcifications,\
Cerebral atrophy, leukodystrophy,\
HSMG, Thrombocytopenia,\
Elevated hepatic transaminases\
Chronic cerebrospinal fluid (CSF) lymphocytosis225750 RNASEH2B deficiency, AGS2Mutations in *RNASEH2B*, encoding nuclease subunit involves in clearing cellular nucleic debris\
610326ARNot assessedNot assessedIntracellular accumulation of abnormal ss-DNA species leading to increased CSF alpha-IFN productionProgressive encephalopathy Intracranial calcifications,\
Cerebral atrophy, leukodystrophy,\
HSMG, thrombocytopenia,\
Elevated hepatic transaminases\
Chronic CSF lymphocytosis610181 RNASEH2C deficiency, AGS3Mutations in *RNASEH2C*, encoding nuclease subunit involves in clearing cellular nucleic debris\
610330ARNot assessedNot assessedIntracellular accumulation of abnormal ss-DNA species leading to increased CSF alpha-IFN productionProgressive encephalopathy Intracranial calcifications,\
Cerebral atrophy, leukodystrophy,\
HSMG, thrombocytopenia,\
Elevated hepatic transaminases\
Chronic CSF lymphocytosis610329 RNASEH2A deficienc y, AGS4Mutations in *RNASEH2A*, encoding nuclease subunit involves in clearing cellular nucleic debris\
606034ARNot assessedNot assessedIntracellular accumulation of abnormal ss-DNA species leading to increased CSF alpha-IFN productionProgressive encephalopathy Intracranial calcifications,\
Cerebral atrophy, leukodystrophy,\
HSMG, thrombocytopenia,\
Elevated hepatic transaminases\
Chronic CSF lymphocytosis610333 SAMHD1 deficiency, AGS5Mutations in *SAMHD1*, encoding negative regulator of the immunostimulatory DNA response\
606754ARNot assessedNot assessedInduction of the cell intrinsic antiviral response, apoptosis, and mitochondrial DNA destruction leading to increased CSF alpha-IFN productionProgressive encephalopathy Intracranial calcifications,\
Cerebral atrophy, leukodystrophy,\
HSMG, thrombocytopenia, anemia elevated lactates\
Chronic CSF lymphocytosis,\
Skin vascularitis, mouth ulcers, arthropathy612952 ADAR1 deficiency, AGS6Mutations in *ADAR1*, encoding a RNA-specific adenosine deaminase\
146920ARNot assessedNot assessedCatalyzes the deamination of adenosine to inosine in dsRNA substrates Markedly elevated CSF IFN-alphaProgressive encephalopathy intracranial calcification,\
Severe developmental delay, leukodystrophy615010 Aicardi-Goutieres syndrome 7 (AGS7)*IFIH1*\
606951ADNot assessedNot assessedIFIH1 gene encodes a cytoplasmic viral RNA receptor that activates type I interferon signaling through the MAVS adaptor moleculeProgressive encephalopathy intracranial calcification,\
Severe developmental delay, leukodystrophy615846 Spondyloenchondro-dysplasia with immune dysregulation (SPENCD)Mutations in *ACP5*, encoding tartrate-resitant acid phosphatase (TRAP)\
171640ARNot assessedNot assessedUpregulation of IFN-alpha and type I IFN-stimulated genesRecurrent bacterial and viral infections,\
Intracranial calcification,\
SLE-like autoimmunity (Sjögren's syndrome, hypothyroidism, inflammatory myositis, Raynaud's disease and vitiligo), hemolytic anemia, thrombocytopenia,\
skeletal dysplasia, short stature607944 STING\--associated vasculopathy, infantile-onset*TMEM173 encoding for* STIMULATOR OF INTERFERON GENES\
612374ARNot assessedNot assessedSTING activates both the NF-kappa-B and IRF3 transcription pathways to induce expression of IFN-alpha and IFN-beta and exert a potent antiviral effectSevere infantile-onset autoinfammatory vasculopathy,615934 ADA2 deficiencyMutations in CECR1; encoding ADA2\
607575ARNot assessedNot assessedADAs deactivate extracellular adenosine and terminate signaling through adenosine receptorsPolyarteritis nodosa, childhood-onset, early-onset recurrent ischemic stroke and fever615688Total no. of genes in Table [4](#Tab4){ref-type="table"}: 37New genes added: *PLDN, CTLA4, TPP2, NFAT5, IFIH1, TMEM173, CECR1, STAT 3 (GOF)XL* X-linked inheritance, *AR* autosomal recessive inheritance, *AD* autosomal dominant inheritance, *FHL* familial hemophagocytic lymphohistiocytosis, *HLH* Hemophagocytic lymphohistiocytosis, *HSMG* hepato-splenomegaly, *DN* double-negative, *SLE* systemic lupus erythematous, *IBD* inflammatory bowel disease, *CSF* chronic cerebrospinal fluid\*\* Somatic mutations of *TNFRSF6* cause a similar phenotype (ALPS-sFAS) see Table [9](#Tab9){ref-type="table"}. Germinal mutation and somatic mutations of *TNFRSF6* can be associated in some ALPS-FAS patients\*\*\* AR ALPS-FAS patients have a most severe clinical phenotype\*\*\*\* Somatic mutations in KRAS or NRAS can give this clinical phenotype associated auto-immune leukoproliferative disease (RALD) and are now include in Table [9](#Tab9){ref-type="table"} entitled Phenocopies of PID\*\*\*\*\* *de novo* dominant TREX1 mutations have been reportedTable 5Congenital defects of phagocyte number, function, or bothDiseaseGenetic defect/\
Presumed pathogenesis\
OMIM geneInheritanceAffected cellsAffected functionAssociated featuresPhenotype\
OMIM number1) Congenital neutropenias Elastase deficiency (SCN1)Mutation in *ELANE:* misfolded protein response, increased apoptosis\
130130ADNMyeloid differentiationSusceptibility to MDS/leukemia202700 GFI 1 deficiency (SCN2)Mutation in *GFI1*: loss of repression of ELANE\
600871ADNMyeloid differentiationB/T lymphopenia613107 Kostmann Disease (SCN3)Mutation in *HAX1*: control of apoptosis\
605998ARNMyeloid differentiationCognitive and neurological defects in patients with defects in both HAX1 isoforms, susceptibility to MDS/leukemia610738 G6PC3 deficiency (SCN4)Mutation in *G6PC3*: abolished enzymatic activity of glucose-6-phosphatase, aberrant glycosylation, and enhanced apoptosis of N and F\
611045ARN + FMyeloid differentiation, chemotaxis,\
O~2~ ^−^ productionStructural heart defects, urogenital abnormalities,\
inner ear deafness, and venous angiectasias of trunks and limbs612541 VPS45 deficiency (SCN5)Mutation in *VPS45 controls vesicular trafficking*\
610035ARN+FMyeloid differentiation, migrationExtramedullary hematopoiesis, bone marrow fibrosis, nephromegaly,615285 Glycogen storage disease\
 type 1bMutation in *G6PT1*: Glucose-6-phosphate transporter 1\
602671ARN + MMyeloid differentiation, chemotaxis,\
O~2~ ^−^ productionFasting hypoglycemia, lactic acidosis, hyperlipidemia, hepatomegaly232220 Cyclic neutropeniaMutation in *ELANE*: misfolded protein response\
130130ADNDifferentiationOscillations of other leukocytes and platelets162800 X-linked neutropenia/ myelodysplasiaMutation in *WAS:* Regulator of actin cytoskeleton (loss of autoinhibition)\
300392XL, gain of functionN + MMitosisMonocytopenia300299 P14/LAMTOR2 deficiencyMutation in *ROBLD3/LAMTOR2*: Endosomal adaptor protein 14\
610389ARN+L\
MelEndosome biogenesisNeutropenia\
Hypogammaglobulinemia\
↓CD8 cytotoxicity\
Partial albinism\
Growth failure610798 Barth SyndromeMutation in Tafazzin (*TAZ*) gene: Abnormal lipid structure of mitochondrial membrane, defective carnitine metabolism\
300394XLNMyeloid differentiationCardiomyopathy, myopathy, growth retardation302060 Cohen syndromeMutation in *COH1* gene: Pg unknown 607817ARNMyeloid differentiationRetinopathy, developmental delay, facial dysmorphisms216550 Clericuzio syndrome\
 Poikiloderma with neutropeniaMutation in *C16ORF57 (USB1)*, affects genomic integrity\
613276ARNMyeloid differentiationPoikiloderma, MDS604173 JAGN1 deficiencyMutations in JAGN1, regulates secretory pathway\
616012ARNMyeloid differentiationSome with a bone phenotype616022 3-Methylglutaconic aciduriaMutations in CLPB\
616254ARNMyeloid differentiationMicrocephaly, hypoglycemia, hypotonia, ataxia, seizures, cataracts, IUGRNot yet assigned G-CSF receptor deficiencyMutations in CSF3R, the growth factor receptor\
138971ARNMyeloid differentiationPoor response to GCSF162830 DiseaseGenetic defect/\
Presumed pathogenesisInheritanceAffected cellsAffected functionAssociated featuresOMIM number2. Defects of Motility Leukocyte adhesion deficiency\
type 1 (LAD1)Mutation in *ITGB2*: B chain for adhesion proteins CD18/CD11\
600065ARN + M +\
L + NKAdherence,\
Chemotaxis,\
Endocytosis,\
T/NK cytotoxicityDelayed cord separation, skin ulcers\
Periodontitis\
Leukocytosis116920 Leukocyte adhesion deficiency type 2 (LAD2)Mutation in *SLC35C1*: GDP-Fucose transporter\
605881ARN + MRolling,\
chemotaxisMild LAD type 1 features\
plus hh-blood group plus mental and growth retardation266265 Leukocyte adhesion deficiency type 3 (LAD3)Mutation in *KINDLIN3*:\
Rap1-activation of β1-3 integrins\
607901ARN + M +\
L + NKAdherence, chemotaxisLAD type 1 plus bleeding tendency612840 Rac 2 deficiencyMutation in *RAC2*: Regulation of actin cytoskeleton\
602049ADNAdherence,\
chemotaxis\
O~2~ ^−^ productionPoor wound healing, leukocytosis608203 β-actin deficiencyMutation in *ACTB*: Cytoplasmic Actin\
102630ADN + MMotilityMental retardation, short stature243310 Localized juvenile periodontitisMutation in *FPR1*: Formylated peptide receptor\
136537ARNFormylpeptide induced chemotaxisPeriodontitis onlyNot assigned Papillon-Lefèvre SyndromeMutation in *CTSC*: Cathepsin C activation of serine proteases\
602365ARN + MChemotaxisPeriodontitis, palmoplantar hyperkeratosis in some patients245000 Specific granule deficiencyMutation in *C/EBPE*: myeloid transcription factor\
189965ARNChemotaxisNeutrophils with bilobed nuclei245480 Shwachman-Diamond SyndromeMutation in *SBDS:* Defective ribosome synthesis607444ARNChemotaxisPancytopenia, exocrine pancreatic insufficiency, chondrodysplasia2604003. Defects of Respiratory Burst X-linked chronic granulomatous disease (CGD)Mutation in *CYBB*: Electron transport protein (gp91phox)\
300481XLN + MKilling (faulty O~2~ ^−^ production)McLeod phenotype in patients with deletions extending into the contiguous Kell locus306400 Autosomal recessive CGDMutation in *CYBA*: Electron transport protein (p22phox)\
608508ARN + MKilling (faulty O~2~ ^−^ production)Infections, autoinflammatory phenotype233690 Autosomal recessive CGDMutation in *NCF1*: Adapter protein (p47phox)\
608512ARN + MKilling (faulty O~2~ ^−^ production)Infections, autoinflammatory phenotype233700 Autosomal recessive CGDMutation in *NCF2*: Activating protein (p67phox)\
608515ARN + MKilling (faulty O~2~ ^−^ production)Infections, autoinflammatory phenotype233710 Autosomal recessive CGDMutation in *NCF4*: Activating protein (p40 phox)\
601488ARN + MKilling (faulty O~2~ ^−^ production)Infections, autoinflammatory phenotype6139604. Other Defects GATA2 deficiency (Mono MAC syndrome)Mutations in *GATA2*: loss of stem cells\
137295ADMonocytes + peripheral DC; low NK cellsMulti lineage cytopeniasSusceptibility to *Mycobacteria*, papilloma viruses, histoplasmosis, alveolar proteinosis, MDS/AML/CMML614286\
614172 Pulmonary alveolar proteinosis\*Mutation in *CSF2RA*\
306250Biallelic mutations in pseudoautosomal geneAlveolar macrophagesGM-CSF signalingAlveolar proteinosis300770Total no. of genes in Table [5](#Tab5){ref-type="table"}: 31New genes added: *JAGN1, CLBP, CSF3R*

Table 6Defects in Intrinsic and Innate ImmunityDiseaseGenetic defect/Presumed pathogenesis\
OMIM geneInheritanceAffected CellFunctional DefectAssociated FeaturesPhenotype\
OMIM Number1. Medelian Susceptibility to mycobacterial disease (MSMD) IL-12 and IL-23 receptor β1 chain deficiencyMutation in *IL12RB1*: IL-12 and IL-23 receptor β1 chain\
601604ARL + NKIFN-γ secretionSusceptibility to *Mycobacteria* and *Salmonella*614891 IL-12p40 deficiencyMutation in *IL12B :* subunit p40 of IL12/IL23\
161561ARMIFN-γ secretionSusceptibility to *Mycobacteria* and *Salmonella*614890 IFN-γ receptor 1 deficiencyMutation in *IFNGR1*:\
IFN-γR ligand binding chain\
107470ARM + LIFN-γ binding and signalingSusceptibility to *Mycobacteria* and *Salmonella*209950 IFN-γ receptor 1 deficiencyMutation in *IFNGR1*:\
IFN-γR ligand binding chain\
107470ADM + LIFN-γ binding and signalingSusceptibility to *Mycobacteria* and *Salmonella*615978 IFN-γ receptor 2 deficiencyMutation in *IFNGR2*: IFN-γR accessory chain\
147569ARM + LIFN-γ signalingSusceptibility to *Mycobacteria* and *Salmonella*614889 STAT1 deficiency (AD form)Mutation in *STAT1* (lost of function)\
600555ADM + LIFN-γsignalingSusceptibility to *Mycobacteria, Salmonella*614892 Macrophage gp91 phox\
  deficiencyMutation in *CYBB*: Electron transport protein (gp 91 phox)\
300481XLMϕ onlyKilling (faulty\
O~2~ ^−^ production)Isolated susceptibility to mycobacteria300645 IRF8-deficiency (AD form)Mutation in *IRF8*: IL12 production by CD1c^+^ MDC\
601565ADCD1c + MDCDifferentiation of CD1c + MDC subgroupSusceptibility to *Mycobacteria*614893 Tyk2 deficiencyMutation in *TYK2*\
176941ARNormal, but\
Multiple cytokine signaling defectNormalSusceptibility to intracellular bacteria (Mycobacteria, Salmonella), fungi and viruses\
(+/−) Elevated IgE611521 ISG15 deficiencyMutation in *ISG15*\
147571ARIFNγ defect productionSusceptibility to Mycobacteria (BCG)\
Brain calcification616126 RORc deficiencyMutation in *RORC*\
602943ARL + NKlack of functional RORγT protein :\
IFNγ defect production\
complete absence of IL-17A/F-producing T cellsmycobacteriosis and candidiasisNot yet assigned2. Epidermodysplasia verruciformis EVER1 deficiencyMutations of *TMC6*\
605828ARKeratinocytes and leukocytesEVER proteins may be involved in the regulation of cellular zinc homeostasis in lymphocytesHPV (group B1) infections and cancer of the skin (typical EV)226400 EVER2 deficiencyMutations of *TMC8*\
605829ARKeratinocytes and leukocytesEVER proteins may be involved in the regulation of cellular zinc homeostasis in lymphocytesHPV (group B1) infections and cancer of the skin (typical EV)226400 WHIM (Warts, Hypogammaglo-bulinemia, infections, Myelokathexis) syndromeGain-of-function mutations of *CXCR4*, the receptor for CXCL12\
162643ADGranulocytes + LymphocytesIncreased response of the CXCR4 chemokine receptor to its ligand CXCL12 (SDF-1)warts/Human Papilloma virus (HPV) infection\
Neutropenia\
Reduced B cell number\
Hypogammaglobulinemia1936704. Predisposition to severe viral infection STAT1 deficiencyMutations of *STAT1*\
600555ART and NK cells and monocytesSTAT1-dependent\
IFN-α, and -β responseSevere viral infections\
Mycobacterial infection613796 STAT2 deficiencyMutations of *STAT2*\
600556ART and NK cellsSTAT2-dependent IFN-α, and -β responseSevere viral infections\
(disseminated vaccine-strain measles)Not yet assigned IRF7 deficiencyMutation in *IRF7*\
605047ARLeukocytes and plasmacytoid dendritic cells,\
Non-hematopoietic cellsIFN-α, and -β production\
IFN-λ productionSevere influenza diseaseNot yet assigned CD16 deficiencyMutation in CD16\
146740ARNK cellsDeficient spontaneous NK cell cytotoxicitySusceptibility to severe viral infections, inc. HSV, EBV, HPV6157075. Herpes simplex encephalitis (HSE) TLR3 deficiency(b) Mutations of *TLR3*\
603029AD\
ARCentral nervous system (CNS) resident cells and fibroblastsTLR3-dependent\
IFN-α, -β, and -λ inductionHerpes simplex virus 1 encephalitis (incomplete clinical penetrance for all etiologies listed here)613002 UNC93B1 deficiency(a) Mutations of *UNC93B1*\
608204ARCNS resident cells and fibroblastsUNC-93B-dependent\
IFN-α, -β, and -λ inductionHerpes simplex virus 1 encephalitis610551 TRAF3 deficiency(c) Mutations of *TRAF3*\
601896ADCNS resident cells and fibroblastsTRAF3-dependent\
IFN-α, -β, and -λ inductionHerpes simplex virus 1 encephalitis614849 TRIF deficiency(c) Mutations of *TRIF, also called TICAM1*\
607601AD\
ARCNS resident cells and fibroblastsTRIF-dependent\
IFN-α, -β, and -λ inductionHerpes simplex virus 1 encephalitis614850 TBK1 deficiency(c) Mutations of *TBK1*\
604834ADCNS resident cells and fibroblastsTBK1-dependent\
IFN-α, -β, and -λ inductionHerpes simplex virus 1 encephalitisNot yet assigned6. Predisposition to invasive fungal diseases CARD9 deficiencyMutations of *CARD9*\
607212ARMononuclear phagocytesCARD9 signaling pathwayInvasive candidiasis infection\
Deep dermatophytoses2120507. Chronic mucocutaneous candidiasis (CMC) IL-17RA deficiency(a) Mutations in *IL17RA*\
605461AREpithelial cells, fibroblasts, mononuclear phagocytesIL-17RA signaling pathwayCMC\
Folliculitis613953 IL-17RC deficiencyMutations in IL17RC\
610925AREpithelial cells, fibroblasts, mononuclear phagocytesIL-17RC signaling pathwayCMCNot yet assigned IL-17F deficiency(b) Mutations in *IL17F*\
606496ADT cellsIL-17 F-containing dimersCMC\
Folliculitis613956 STAT1 gain-of-function(c) gain-of-function mutations in *STAT1*\
600555ADT cells, B cells, monocytesGain-of-function STAT1 mutations that impair the development of IL-17-producing T cellsCMC\
Various fungal, bacterial and viral (HSV) infections\
Auto-immunity (Thyroiditis, diabetes, cytopenia)\
Enteropathy614162 ACT1 deficiency(c) Mutations in *ACT1,* also called *TRAF3IP2*\
(607043)ART cells, fibroblastsFibroblasts fail to respond to IL-17A and IL-17 F, and their T cells to IL-17ECMC\
Blepharitis, Folliculitis and macroglossia6155278. TLR signaling pathway deficiency IRAK-4 deficiencyMutations of *IRAK4*, a component of TLR- and IL-1R-signaling pathway\
606883ARLymphocytes + Granulocytes + MonocytesTIR-IRAK signaling pathwayBacterial infections (pyogens)607676 MyD88 deficiencyMutations of *MYD88*, a component of the TLR and IL-1R signaling pathway\
602170ARLymphocytes + Granulocytes + MonocytesTIR-MyD88 signaling pathwayBacterial infections (pyogens)6122609. Isolated congenital asplenia (ICA)Mutations in *RPSA*\
150370ADSpleenRPSA encodes ribosomal protein SA, a component of the small subunit of the ribosomeBacteremia (encapsulated bacteria)\
No spleen2714008. TrypanosomiasisMutations in *APOL- I* 603743ADAPOL-ITrypanosomiasisNot yet assignedTotal no. of gene defects in Table [6](#Tab6){ref-type="table"}: 32New genes added : *RORC, IRF7, IL17RC, APOL-1XL* X-linked inheritance, *AR* autosomal recessive inheritance, *AD* autosomal dominant inheritance, *NF-κB* nuclear factor Kappa B, *TIR* Toll and Interleukin 1 Receptor, *IFN* interferon, *HVP* human papilloma virus, *TLR* Toll-like receptor, *IL* interleukinTable 7Autoinflammatory disordersDiseaseGenetic defect/\
Presumed pathogenesis\
OMIN geneInheritanceAffected cellsFunctional defectsAssociated FeaturesPhenotype\
OMIM number1. Defects effecting the inflammasome Familial Mediterranean FeverMutations of *MEFV (lead to gain of pyrin function, resulting in inappropriate IL-1β release)*\
608107AR\
ADMature granulocytes, cytokine-activated monocytes.Decreased production of pyrin permits ASC-induced IL-1 processing and inflammation following subclinical serosal injury; macrophage apoptosis decreased.Recurrent fever, serositis and inflammation responsive to colchicine. Predisoposes to vasculitis and inflammatory bowel disease.249100\
134610 Mevalonate kinase deficiency (Hyper IgD syndrome)Mutations of *MVK (lead to a block in the mevalonate pathway. Interleukin-1beta mediates the inflammatory phenotype)*\
251170ARaffecting cholesterol synthesis; pathogenesis of disease unclearPeriodic fever and leukocytosis with high IgD levels260920 Muckle-Wells syndromeMutations of *NLRP3* (also called *NALP3 CIAS1 or PYPAF1*) (*lead to constitutive activation of the NLRP3 inflammasome)*\
606416*AD*PMNs MonocytesDefect in cryopyrin, involved in leukocyte apoptosis and NFkB signaling and IL-1 processingUrticaria, SNHL, amyloidosis.191900 Familial cold autoinflammatory syndrome 1Mutations of NLRP3 (See above)\
606416*ADPMNs, monocytes*same as aboveNon-pruritic urticaria, arthritis, chills, fever and leukocytosis after cold exposure.120100 Familial cold\
autoinflammatory syndrome 2Mutations of NLRP12\
609648*ADPMNs, monocytes*same as aboveNon-pruritic urticaria, arthritis, chills, fever and leukocytosis after cold exposure.611762 Neonatal onset multisystem\
  inflammatory disease\
  (NOMID) or chronic infantile\
  neurologic cutaneous and\
  articular syndrome (CINCA)Mutations of NLRP3\
CIAS1 (See above)\
606416*ADPMNs, chondrocytes*same as aboveNeonatal onset rash, chronic meningitis, and arthropathy with fever and inflammation*.*607115 NLRC4-MAS (macrophage activating syndrome)\
 Familial cold\
  autoinflammatory syndrome 4Mutation in NLRC4 (see functional defect)\
606831*ADPMNs monocytes macrophages*Gain of function mutation in NLRC4 results in elevated secretion of IL-1β and IL-18 as well as macrophage activationSevere enterocolitis and macrophage activation syndrome616050\
616115 PLAID (PLCγ2 associated antibody deficiency and immune dysregulation)\
 Familial cold\
  autoinflammatory syndrome 3Mutation in *PLCG2* ((see functional defect)\
600220ADB cells, NK, Mast cellsMutations cause activation of IL-1 pathwaysCold urticaria hypogammaglobulinemia614468 APLAID (autoinflammation and PLCγ2 associated antibody deficiency and immune dysregulation)Mutation (c2120C \> A) in PLCG2 (see function defect)\
600220ADB cells, NK, mast cellsThe mutation leads to activation of the NLRP3 inflammasome (not provoked by cold temperature)Blistering skin lesion, pulmonary and bowel disease6148782. Non inflammasome-related conditions (TNF receptor-associated\
 periodic syndrome (TRAPS)Mutations of *TNFRSF1A* (resulting in increased TNF inflammatory signaling)\
191190ADPMNs, monocytesMutations of 55-kD TNF receptor leading to intracellular receptor retention or diminished soluble cytokine receptor available to bind TNFRecurrent fever, serositis, rash, and ocular or joint inflammation142680 Pyogenic sterile arthritis,\
  pyoderma gangrenosum,\
  acne (PAPA) syndromeMutations of *PSTPIP1* (also called *C2BP1)* (affects both pyrin and protein tyrosine phosphatase to regulate innate and adaptive immune responses)\
606347ADHematopoietic tissues, upregulated in activated T-cellsDisordered actin reorganization leading to compromised physiologic signaling during inflammatory responseDestructive arthritis, inflammatory skin rash, myositis604416 Blau syndromeMutations of *NOD2* (also called CARD15) (involved in various inflammatory processes)\
605956ADMonocytesMutations in nucleotide binding site of CARD15, possibly disrupting interactions with lipopolysaccharides and NF-κB signalingUveitis, granulomatous synovitis, camptodactyly, rash and cranial neuropathies, 30 % develop Crohn's disease186580 ADAM17 deletionMutation in *ADAM17* (leads to tumor necrosis factor α converting enzyme deficiency)\
603639ARLeukocytes and epithelial cellsDefective TNFα productionEarly onset diarrhea and skin lesions614328 Chronic recurrent multifocal osteomyelitis and congenital\
  dyserythropoietic anemia\
  (Majeed syndrome)Mutations of *LPIN2* (increased expression of the proinflammatory genes)\
605519ARNeutrophils, bone marrow cellsundefinedChronic recurrent multifocal osteomyelitis, transfusion-dependent anemia, cutaneous inflammatory disorders609628 DIRA (Deficiency of the\
  Interleukin 1 Receptor\
  Antagonist)Mutations of *IL1RN* (see functional defect)\
147679ARPMNs, MonocytesMutations in the IL1 receptor antagonist allow unopposed action of Interleukin 1Neonatal onset of sterile multifocal osteomyelitis, periostitis and pustulosis.612852 DITRA -- Deficiency of IL-36 receptor antagonistMutation in *IL36RN* (see functional defect)\
605507ARKeratinocyte LeukocytesMutations in IL-36RN leads to increase IL-8 productionPustular Psoriasis614204 SLC29A3 mutationMutation in *SLC29A3*\
612373ARLeukocyte, bone cellsHyperpigmentation hypertrichosisHistiocytosis-lymphadenopathy plus syndrome602782 CAMPS (CARD14 mediated psoriasis)Mutation in *CARD14* (see functional defect)\
607211ADMainly in KeratinocyteMutations in CARD14 activate the NF-*k*B pathway and production of IL-8Psoriasis602723 CherubismMutation in *SH3BP2* (see functional defect)\
602104ADStroma cells, bone cellsHyperactived macrophage and increase NF-kBBone degeneration in jaws118400 CANDLE (chronic atypical neutrophilic dermatitis with lipodystrophy)Mutation in *PSMB8*,\
(see functional defect)\
177046ARKeratinocyte, B cell adipose cellsMutations cause increase IL-6 productionDystrophy, panniculitis256040 COPA defectMutation in COPA (Coatamer protein complex, subunit alpha)ADPMNs and tissues specific cellsMutant COPA leads to defective intracellular transport via the coat protein complex I (COPI)Autoimmune inflammatory arthritis and interstitial lung disease with Th17 dysregulation and autoantibody production601924Total no. of gene defects in Table [7](#Tab7){ref-type="table"}: 17New genes added: *NLRC4, ADAM17, COPA*Notes: Autoinflammatory diseases are clinical disorders marked by abnormally increased inflammation, mediated predominantly by the cells and molecules of the innate immune system, with a significant host predisposition. While the genetic defect of one of the most common autoinflammatory conditions, PFAPA, is not known, recent studies suggest that it is associated with activation of IL-1 pathway and response to IL-1beta antagonistsMuckle-Wells syndrome, familial cold autoinflammatory syndrome and neonatal onset multisystem inflammatory disease (NOMID) which is also called chronic infantile neurologic cutaneous and articular syndrome (CINCA) are caused by similar mutations in *CIAS1/NLRP3* mutations. The disease phenotype in any individual appears to depend on modifying effects of other genes and environmental factors*AR* autosomal recessive inheritance, *AD* autosomal dominant inheritance, *PMN* polymorphonuclear cells, *ASC* apoptosis-associated speck-like protein with a caspase recruitment domain, *CARD* caspase recruitment domain, *CD2BP1* CD2 binding protein-1, *PSTPIP1* Proline/serine/threonine phosphatase-interacting protein 1, *SNHL* sensorineural hearing loss, *CIAS1* cold-induced autoinflammatory syndrome 1Table 8Complement deficienciesDiseaseGenetic defect; presumed pathogenesis\
OMIM geneInheritanceLaboratory featuresAssociated FeaturesPhenotype\
OMIM number1) Integral complement cascade component deficiencies C1q deficiency*C1QA,*: Classical complement pathway component\
120550ARAbsent CH50 hemolytic activity, Defective activation of the classical pathway\
Diminished clearance of apoptotic cellsSLE, infections with encapsulated organisms613652 C1q deficiency*C1QB:* Classical complement pathway component\
120570ARAbsent CH50 hemolytic activity, Defective activation of the classical pathway\
Diminished clearance of apoptotic cellsSLE, infections with encapsulated organisms613652 C1q deficiency*C1QC:* Classical complement pathway component\
120575ARAbsent CH50 hemolytic activity, Defective activation of the classical pathway\
Diminished clearance of apoptotic cellsSLE, infections with encapsulated organisms613652 C1r deficiency*C1R*: Classical complement pathway component\
613785ARAbsent CH50 hemolytic activity, Defective activation of the classical pathwaySLE, infections with encapsulated organisms216950 C1s deficiency*C1S*: Classical complement pathway component\
120580ARAbsent CH50 hemolytic activity\
Defective activation of the classical pathwaySLE, infections with encapsulated organisms613783 C4 deficiency*C4A,* Classical complement pathway components\
120810ARAbsent CH50 hemolytic activity, Defective activation of the classical pathway\
Complete deficiency requires biallelic mutations/deletions/conversions of both C4A and C4BSLE, infections with encapsulated organisms614380 C4 deficiency*C4B*: Classical complement pathway components\
120820ARAbsent CH50 hemolytic activity, Defective activation of the classical pathway\
Complete deficiency requires biallelic mutations/deletions/conversions of both C4A and C4BSLE, infections with encapsulated organisms614379 C2 deficiency*C2*: Classical complement pathway component\
217000ARAbsent CH50 hemolytic activity, Defective activation of the classical pathwaySLE, infections with encapsulated organisms, atherosclerosis613927 C3 deficiency\
LOF*C3*: Central complement component\
120700ARAbsent CH50 and AH50 hemolytic activity\
Defective opsonization\
Defective humoral immune responseInfections; glomerulonephritis;\
Atypical Hemolytic-uremic syndrome with gain-of-function mutations.613779 C3 GOF*C3*: Central complement component\
120700Gain-of-function ADIncreased activation of complementAtypical Hemolytic-uremic syndrome612925 C5 deficiency*C5*: Terminal complement component\
120900ARAbsent CH50 and AH50 hemolytic activity\
Defective bactericidal activityNeisserial infections609536 C6 deficiency*C6*: Terminal complement component\
217050ARAbsent CH50 and AH50 hemolytic activity\
Defective bactericidal activityNeisserial infections612446 C7 deficiency*C7*: Terminal complement component\
217070ARAbsent CH50 and AH50 hemolytic activity\
Defective bactericidal activityNeisserial infections610102 C8 αdeficiency*C8A*: Terminal complement component\
120950ARAbsent CH50 and AH50 hemolytic activity\
Defective bactericidal activityNeisserial infections613790 C8γ deficiency*C8G:* Terminal complement component\
120930ARAbsent CH50 and AH50 hemolytic activity\
Defective bactericidal activityNeisserial infections613790 C8β deficiency*C8B*: Terminal complement component\
120960ARAbsent CH50 and AH50 hemolytic activity\
Defective bactericidal activityNeisserial infections613789 C9 deficiency*C9*: Terminal complement component\
120940ARReduced CH50 and AP50 hemolytic activity\
Deficient bactericidal activityMild susceptibility to Neisserial infections613825 MASP2 deficiency*MASP2*: Cleavage of C4\
605102ARDeficient activation of the lectin activation pathwayPyogenic infections;\
Inflammatory lung disease, autoimmunity613791 Ficolin 3 deficiency*FCN3:* Activates the classical complement pathway\
604973ARAbsence of complement activation by the Ficolin 3 pathway.Respiratory infections, abscesses6138602) Complement Regulatory defects C1 inhibitor deficiency*SERPING1*: regulation of kinins and complement activation\
606860ADSpontaneous activation of the complement pathway with consumption of C4/C2\
Spontaneous activation of the contact system with generation of bradykinin from high molecular weight kininogenHereditary angioedema106100 Factor B*CFB:* Activation of the alternative pathway\
138470ADGain-of-function mutation with increased spontaneous AH50aHUS612924 Factor D deficiency*CFD*: Regulation of the alternative complement pathway\
134350ARAbsent AH50 hemolytic activityNeisserial infections613912 Properdin deficiency*CFP*: Regulation of the alternative complement pathway\
300383XLAbsent AH50 hemolytic activityNeisserial infections312060 Factor I deficiency*CFI*: Regulation of the alternative complement pathway\
217030ARSpontaneous activation of the alternative complement pathway with consumption of C3Infections, Neisserial infections, aHUS, preeclampsia610984\
612923 Factor H deficiency*CFH*: Regulation of the alternative complement pathway\
134370AR/ADSpontaneous activation of the alternative complement pathway with consumption of C3Infections, Neisserial infections, aHUS, preeclampsia609814\
235400 Factor H --related protein deficiencies*CFHR1-5*: Bind C3b\
134371\
600889\
605336\
605337\
608593AR/ADNormal CH50, AH50, autoantibodies to Factor H. Linked deletions of one or more CFHR genes leads to susceptibility autoantibody-mediated aHUSaHUS, Neisserial infections235400 Thrombomodulin*THBD*: Regulates complement and coagulant activation\
188040ADNormal CH50, AH50aHUS612926 Complement Receptor 3 (CR3) deficiency*ITGAM*\
120980ARCR3 expression is lost in LAD1. See LAD1 in Table [5](#Tab5){ref-type="table"}Infections609939 Membrane Cofactor Protein (CD46) deficiency*CD46*: Dissociates C3b and C4b\
120920ADInhibitor of complement alternate pathway, decreased C3b bindingaHUS, infections, preeclampsia612922 Membrane Attack Complex Inhibitor (CD59) deficiency*CD59:* Regulates the membrane attack complex formation\
107271ARErythrocytes highly susceptible to complement-mediated lysisHemolytic anemia, polyneuropathy612300Total no. of genes Tables [8](#Tab8){ref-type="table"} and [9](#Tab9){ref-type="table"}: 30No new genes added to the 2015 classification*XL* X-linked inheritance, *AR* autosomal recessive inheritance, *AD* autosomal dominant inheritance, *MAC* membrane attack complex, *SLE* systemic lupus erythematosus, *MASP* MBP associated serine protease 2Table 9Phenocopies of PIDDiseaseGenetic defect/presumed pathogenesisCirculating T cellsCirculating B cellsSerum IgAssociated features/similar PIDAssociated with somatic mutations Autoimmune lymphoproliferative syndrome (ALPS--SFAS)Somatic mutation in *TNFRSF6*Increased CD4−CD8−double negative (DN) T alpha/beta cellsNormal, but increased number of CD5+ B cellsNormal or increasedSplenomegaly, lymphadenopathy, autoimmune cytopenias\
Defective lymphocyte apoptosis/*ALPS--FAS (=ALPS type Im)* RAS-associated autoimmune leukoproliferative disease (RALD)Somatic mutation in *KRAS* (gain-of-function)NormalB cell lymphocytosisNormal or increasedSplenomegaly, lymphadenopathy, autoimmune cytopenias, granulocytosis, monocytosis/*ALPS-like* RAS-associated autoimmune leukoproliferative disease (RALD)Somatic mutation in *NRAS* (gain-of-function)Increased CD4−CD8−double negative (DN) T alpha/beta cellsLymphocytosisSplenomegaly, lymphadenopathy, autoantibodies/*ALPS-like* Cryopyrinopathy, (Muckle-Wells /CINCA/NOMID-like syndrome)Somatic mutation in *NLRP3*NormalNormalNormalUrticaria-like rash, arthropathy, neurological symptomsAssociated with autoantibodies Chronic mucocutaneous candidiasis (isolated or with APECED syndrome)Germline mutation in *AIRE* AutoAb to IL-17 and/or IL-22NormalNormalNormalEndocrinopathy, chronic mucocutaneous candidiasis/*CMC* Adult-onset immunodeficiencyAutoAb to IFN gammaDecreased naive T cellsNormalNormalMycobacterial, fungal, *Salmonella* VZV infections/*MSMD, or CID* Recurrent skin infectionAutoAb to IL-6NormalNormalNormalStaphylococcal infections/*STAT3 deficiency* Pulmonary alveolar proteinosisAutoAb to GM-CSFNormalNormalNormalPulmonary alveolar proteinosis, cryptococcal meningitis/*CSF2RA deficiency* Acquired angioedemaAutoAb to CI inhibitorNormalNormalNormalAngioedema/*C1 INH deficiency* (hereditary angioedema) Atypical Hemolytic Uremic SyndromeAutoAb to Complement Factor HNormalNormalNormalaHUS\
Spontaneous activation of the alternative complement pathwayThe classification this year differs in a number of ways from the previous edition published in 2014. Importantly, each defect is now listed in only one table. The diverse immunological phenotypes of many conditions imply that a very large number of conditions could very readily be listed in multiple tables. However, with the increasing number of identified defects, this would make each table large and cumbersome. For this reason, we chose to list each defect in one table only and to place it according to the most pronounced and fundamental defect. For this reason and as an example, CD40L deficiency is now found in Table [1](#Tab1){ref-type="table"} amongst combined immunodeficiencies, because CD40L is a T cell signaling molecule whose absence leads to both cellular and humoral defects, even though it was originally described as an antibody deficiency. Although some of our placements may be disputed, the committee came to these decisions after much thought and deliberation.

The title of Table [6](#Tab6){ref-type="table"} has now been slightly changed to 'Defects in intrinsic and innate immunity' and contains defects characterized by susceptibility to specific organisms. For this reason, the MSMDs (Mendelian Susceptibility to Mycobacterial Disease) are now in Table [6](#Tab6){ref-type="table"}, having previously been in Table [5](#Tab5){ref-type="table"} (Phagocytic Disorders).

In previous editions, we have placed an asterisk against conditions in which 10 or fewer individuals had been described in the literature. However, this is now felt to be an artificial indicator as, once described, a condition may be found in additional patients but not necessarily reported. For this reason, there is no specific indicator of the number of patients identified or reported.

There is a growing appreciation of wide phenotypic variability for many of the individual specific gene defects, reflecting not only the variety of mutations within each gene but also host and/or environmental modifying factors that may impact the phenotype even between individuals with the same mutation within the same gene. The complexities of these conditions in terms of clinical and immunological presentation and heterogeneity cannot easily be captured in the limited space of a table format. For this reason, the furthest right column contains the Online Mendelian Inheritance in Man (OMIM) reference for each condition to allow access to a source of greater detail and updated information as to the phenotype.

A number of the new genes included in this edition of the classification tables are molecules associated not only with the immune system, but also with more generic cellular functions; such defects result in both immunological and non-immunological abnormalities. In addition, there are a number of gain-of-function (GOF) mutations identified such as in PIK3CD. In CARD11 and STAT1 for example, there are both autosomal dominant GOF and autosomal recessive loss of function variants and these different modes of inheritance in the same gene lead to different functional consequences and hence different immunological and clinical phenotypes. The other trend that is increasingly observed is the increase in disorder of immunedysregulation rather than pure immunodeficiency.

The goal of the IUIS Expert Committee on Primary Immunodeficiencies is to increase awareness, facilitate recognition and promote optimal treatment for patients with Primary Immunodeficiencies. In addition to the current report and previous 'classification table' publications, the committee has also produced a 'Phenotypic Approach for IUIS PID classification and Diagnosis: Guidelines for Clinicians at the Bedside,' which aims to lead physicians to particular groups of PIDs starting from clinical features and combining routine immunological investigations. This will be further updated to include the newly identified defects. Together these contributions will hopefully allow a practical clinical framework for PID diagnosis.
